These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 24032657)
21. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882 [TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464 [TBL] [Abstract][Full Text] [Related]
23. [Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers]. Zhou H; Qiu LP; Yan XX; Li L; Li X; Wang L; Liu M; Wang DK Yao Xue Xue Bao; 2010 Sep; 45(9):1177-82. PubMed ID: 21351576 [TBL] [Abstract][Full Text] [Related]
24. Long circulation nanostructured lipid carriers for gambogenic acid: formulation design, characterization, and pharmacokinetic. Lin T; Huang X; Wang Y; Zhu T; Luo Q; Wang X; Zhou K; Cheng H; Peng D; Chen W Xenobiotica; 2017 Sep; 47(9):793-799. PubMed ID: 27618478 [TBL] [Abstract][Full Text] [Related]
25. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
26. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride. Ranpise NS; Korabu SS; Ghodake VN Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002 [TBL] [Abstract][Full Text] [Related]
27. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122 [TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers. Li F; Weng Y; Wang L; He H; Yang J; Tang X Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221 [TBL] [Abstract][Full Text] [Related]
29. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405 [TBL] [Abstract][Full Text] [Related]
30. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233 [TBL] [Abstract][Full Text] [Related]
31. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers. Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361 [TBL] [Abstract][Full Text] [Related]
32. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. Liu R; Liu Z; Zhang C; Zhang B J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401 [TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of solid lipid nanoparticles containing peptide. Hu FQ; Hong Y; Yuan H Int J Pharm; 2004 Apr; 273(1-2):29-35. PubMed ID: 15010127 [TBL] [Abstract][Full Text] [Related]
35. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Das S; Ng WK; Tan RB Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358 [TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Huang ZR; Hua SC; Yang YL; Fang JY Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178 [TBL] [Abstract][Full Text] [Related]
37. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282 [TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of puerarin-loaded controlled release nanostructured lipid carries by central composite design. Ye Q; Li J; Li T; Ruan J; Wang H; Wang F; Zhang X Drug Dev Ind Pharm; 2021 Jan; 47(1):113-125. PubMed ID: 33289579 [TBL] [Abstract][Full Text] [Related]
39. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
40. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel. Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]